Literature DB >> 31387823

Clinical and procedural predictors and short-term survival of the patients with no reflow phenomenon after primary percutaneous coronary intervention.

Tariq Ashraf1, Muhammad Nauman Khan2, Syed Muhammad Afaque2, Kanwal Fatima Aamir2, Mukesh Kumar2, Tahir Saghir2, Syed Ishtiaq Rasool2, Syed Nadeem Hassan Rizvi2, Jawaid Akbar Sial2, Asif Nadeem3, Abid Amin Khan4, Musa Karim2.   

Abstract

OBJECTIVES: In the present study, we analysed the incidence of no-reflow phenomenon, its clinical and procedural predictors, and associated in-hospital outcomes for the patients undergoing primary percutaneous coronary intervention (PCI).
BACKGROUND: No-reflow phenomenon after primary PCI is a procedural complication associated with adverse post-procedure outcomes.
METHODS: Data for this study were extracted from global registry, NCDR®, the site of National Institute of Cardiovascular Disease (NICVD), Karachi from July 2017 to March 2018. The demographic, clinical, and procedural characteristics, and in-hospital outcomes were analysed for the patients with and without no-reflow after primary PCI.
RESULTS: Of total of 3255 patients, no-reflow phenomenon was found in 132 (4.1%) patients and it was associated with significantly higher in-hospitality mortality (6.8% vs. 2.9%; p = 0.01), cerebrovascular accident (1.5% vs. 0%; p < 0.001), post procedure bleeding (2.3% vs. 0.5%; p = 0.009), and cardiogenic shock (3.8% vs. 1.2%; p = 0.011). The multivariate analysis showed advanced age [odds ratio = 1.63, 95% confidence interval 1.09-2.44, p = 0.018], diabetes [1.66, 1.14-2.42, p = 0.009], prior history of CABG [8.70, 1.45-52.04, p = 0.018], low pre-procedure TIMI flow grade [2.04, 1.3-3.21, p = 0.002], longer length of target lesion [1.51, 1.06-2.16, p = 0.023], and 10 fold raised troponin I [1.55, 1.08-2.23, p = 0.018] were the independent predictors of no-reflow.
CONCLUSIONS: In this selected group of patients, the no-reflow phenomenon after primary percutaneous coronary intervention is not that uncommon. It is associated with an increased risk of adverse post-procedure hospital course including mortality. Pathophysiology of the no-reflow phenomenon is complex and opaque, however, it can be predicted based on certain clinical and procedural characteristics.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  No-reflow phenomenon; Percutaneous coronary interventions; ST elevation myocardial infarction (STEMI)

Mesh:

Substances:

Year:  2019        PMID: 31387823     DOI: 10.1016/j.ijcard.2019.07.067

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  Machine learning to predict no reflow and in-hospital mortality in patients with ST-segment elevation myocardial infarction that underwent primary percutaneous coronary intervention.

Authors:  Lianxiang Deng; Xianming Zhao; Xiaolin Su; Mei Zhou; Daizheng Huang; Xiaocong Zeng
Journal:  BMC Med Inform Decis Mak       Date:  2022-04-24       Impact factor: 3.298

2.  Multivessel Coronary Artery Disease and Subsequent Thrombolysis in Myocardial Infarction Flow Grade After Primary Percutaneous Coronary Intervention.

Authors:  Haris Majeed; Muhammad N Khan; Khalid Naseeb; Najia A Soomro; Saeed Alam; Shahid Ahmed; Usman Bhatti; Tahir Saghir
Journal:  Cureus       Date:  2020-06-21

3.  Clinical, Laboratory, and Procedural Predictors of No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Maryam Shakiba; Arsalan Salari; Fardin Mirbolouk; Nozar Sotudeh; Salman Nikfarjam
Journal:  J Tehran Heart Cent       Date:  2020-04

4.  CHA2 DS2 -VASc score, a simple clinical tool for early prediction of no-reflow phenomenon in patients undergoing emergency percutaneous coronary revascularization.

Authors:  Abdul Hakeem Shaikh; Rajesh Kumar; Ali Ammar; Afzal Hussain; Muhammad Naeem Mengal; Kamran Ahmed Khan; Danish Qayyum; Jawaid Akbar Sial; Tahir Saghir; Musa Karim
Journal:  J Cardiovasc Thorac Res       Date:  2022-06-25

5.  Clinical Manifestation of Cardiac Rupture in Patients with ST-Segment Elevation Myocardial Infarction: Early Versus Late Primary Percutaneous Coronary Intervention.

Authors:  Xile Bi; Bin Wang; Gary Tse; Cuilian Dai; Xiang Chen; Fanqi Meng; Yan Wang
Journal:  Glob Heart       Date:  2022-09-30

6.  Association between Variation of Troponin and Prognosis of Acute Myocardial Infarction before and after Primary Percutaneous Coronary Intervention.

Authors:  Xiaoxiao Zhao; Ying Wang; Chen Liu; Peng Zhou; Zhaoxue Sheng; Jiannan Li; Jinying Zhou; Runzhen Chen; Yi Chen; Hanjun Zhao; Hongbing Yan
Journal:  J Interv Cardiol       Date:  2020-07-25       Impact factor: 2.279

7.  No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient.

Authors:  Andrea Buono; Tommaso Gori
Journal:  Int J Cardiol Heart Vasc       Date:  2019-08-30

Review 8.  Predictors of Microvascular Reperfusion After Myocardial Infarction.

Authors:  Daniel J Doherty; Robert Sykes; Kenneth Mangion; Colin Berry
Journal:  Curr Cardiol Rep       Date:  2021-02-23       Impact factor: 2.931

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.